Bionesp 40 Injection
Marketer
Eris Lifesciences Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Bionesp 40 Injection
Erythropoiesis-stimulating agent Bionesp 40 Injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under strict medical supervision, Bionesp 40 carries a risk of severe adverse reactions, mandating expert medical management. Adherence to the physician's instructions is crucial. Common side effects encompass abdominal discomfort, hypertension, skin eruptions, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms indicative of dangerously elevated blood pressure—intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests, monitoring electrolyte (potassium) levels, hemoglobin, and blood cell counts, are typically conducted. Discontinue use and seek medical counsel if shortness of breath or a skin rash develops. Prior to initiation, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals should consult their physician regarding safety.
Primary Ingredients of Bionesp 40 Injection
There is no text provided to rephrase.
Uses of Bionesp 40 Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Bionesp 40 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bionesp 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Bionesp 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Bionesp 40 Injection works:
Bionesp 40 Injection is an erythropoietin-based medication that boosts red blood cell production. This is achieved by stimulating the bone marrow, the blood cell-forming tissue within bones, to increase its output of red blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bionesp 40 Injection has an undetermined safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Bionesp 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Bionesp 40 Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Bionesp 40 Injection.
KidneySAFE IF PRESCRIBED
Bionesp 40 Injection poses no safety concerns for individuals with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with hepatic impairment should use Bionesp 40 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bionesp 40 Injection :
Should you forget a Bionesp 40 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bionesp 40 Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | Erythropoietin-stimulating drug |



